0001144204-11-020631.txt : 20110407 0001144204-11-020631.hdr.sgml : 20110407 20110407095855 ACCESSION NUMBER: 0001144204-11-020631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110406 FILED AS OF DATE: 20110407 DATE AS OF CHANGE: 20110407 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLETCHER MARK CENTRAL INDEX KEY: 0001229529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 11744847 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J2G2 4 1 v217837_ex.xml X0303 4 2011-04-06 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001229529 FLETCHER MARK 33 HARBOUR SQUARE SUITE 102 TORONTO ONTARIO CANADA A1 M5J2G2 BRITISH COLUMBIA, CANADA 0 1 0 0 See Remarks Common Stock 2011-04-06 4 P 0 20000 0.239 A 286077 D President, CEO, General Counsel and Secretary /s/ Mark Fletcher 2011-04-06